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OBJECTIVES We sought to determine if echocardiography enhances prediction of first age-related
cardiovascular events.
BACKGROUND Whether echocardiographic assessment improves risk stratification for first cardiovascular
events is not well known.
METHODS This retrospective cohort study included randomly selected residents of Olmsted County,
Minnesota, age 65 years, who had 1 transthoracic echocardiograms at the Mayo Clinic
between 1990 and 1998, in sinus rhythm, without valvular or congenital heart disease, and
followed through medical records for first myocardial infarction (MI), coronary revascular-
ization, atrial fibrillation (AF), congestive heart failure (CHF), transient ischemic attack
(TIA), stroke, or cardiovascular death. Patients were excluded if they had any of these events
before the baseline echocardiogram.
RESULTS Of 1,160 patients (age 75 7 years; 746 women) followed for a mean of 3.8 2.7 years, 333
(29%) first events occurred (70 AF, 67 coronary revascularization procedures, 65 CHF, 48
MI, 38 stroke, 25 TIA, and 20 cardiovascular deaths). In a multivariate model, age (p 
0.001), male gender (p  0.001), diabetes mellitus (p  0.005), systemic hypertension (p 
0.001), left atrial volume/body surface area 32 ml/m2 (p  0.003), left ventricular (LV)
mass/height 120 g/m (p  0.014), LV systolic dysfunction (p  0.001), and LV diastolic
dysfunction (p  0.029) were independent predictors. A risk-scoring algorithm was
developed and validated for the prediction of first events. The five-year event-free survival was
90%, 74%, and 50% for low-, medium-, and high-risk groups, respectively.
CONCLUSIONS Echocardiography enhanced prediction of first cardiovascular events in this referral-based
elderly cohort. Its role in risk stratification for primary prevention of these events in the
community warrants further investigations. (J Am Coll Cardiol 2003;42:1199–205)
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Congestive heart failure (CHF) and atrial fibrillation (AF)
have reached epidemic proportions in the U.S. (1,2). Cor-
onary heart disease remains the number one cause of death
in the country, while stroke is the leading cause of disability
for both men and women (3). The magnitude of these
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age-related conditions is expected to increase because of the
burgeoning older population. Significant progress has been
made in the evaluation and treatment of certain clinical risk
factors for primary and secondary prevention of cardiovas-
cular diseases. The value of echocardiographic assessment of
subclinical abnormalities for stratification of risk for age-
related cardiovascular outcomes is not well known.
Our aim in this study was to determine, within an elderly
cohort, which subclinical abnormalities detected by nonin-
vasive echocardiography are predictive of first age-related
cardiovascular events including CHF, AF, myocardial in-
farction (MI), coronary revascularization, stroke, transient
ischemic attack (TIA), and cardiovascular death. We hy-
pothesized that certain abnormalities, which may not be
clinically overt, portend greater risk for future cardiovascular
events, independent of and incremental to conventional
clinical cardiovascular risk factors.
METHODS
Study design and population. A retrospective cohort de-
sign was used. After obtaining approval from the Mayo
Foundation Institutional Review Board, a list of potential
subjects was identified from a computerized search of the
echocardiography database. Search criteria were residence in
Olmsted County, Minnesota, and record of 1 transtho-
racic echocardiograms performed at Mayo Clinic or Olm-
sted Medical Center or their affiliated hospitals between
January 1, 1990, and December 31, 1998. Olmsted County
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is relatively isolated geographically, with healthcare pro-
vided by a few well-defined health providers, the largest of
which is Mayo Clinic, which provides all echocardiographic
services. In a prior study, it was demonstrated that 96% of
Olmsted County residents age 65 to 74 years had 1
encounters with the Mayo medical system within a three-
year period (4).
The population from which the study sample was drawn
included all Olmsted County residents of age 65 years,
who were referred for a transthoracic echocardiogram be-
tween 1990 and 1998 and had provided permission to use
their records for research purposes. The earliest examination
within the study period was designated as the baseline study.
The list of patients was cross-referenced with the comput-
erized Mayo Clinic registration file, medical index (contain-
ing diagnostic codes), surgical database, and electrocardio-
graphic database. These administrative databases allowed
screening of patients with conditions that were exclusion
criteria. A total of 3,520 patients remained eligible after
cross-referencing the administrative databases, and a ran-
dom sample of 2,240 (64%) was drawn by SAS random
number selection program. Retrospective comprehensive
review of the Mayo Clinic medical records of these 2,240
patients was undertaken. During this review, a further 1,080
patients were excluded, 942 of these owing to baseline
presence of more than mild valvular disease by echocardio-
graphic criteria, and 138 because of presence of exclusion
criteria not detected by the administrative databases. The
remaining 1,160 patients constituted the study population.
Clinical and echocardiographic data. The medical records
of each of the 1,160 eligible patients were comprehensively
reviewed for the clinical data. The indication for echocar-
diography was directly retrieved from a specific field from
the Echocardiography Laboratory database called “indica-
tion or referral diagnosis,” which had to be entered at the
time of booking for echocardiography study. The definitions
of coronary artery disease, peripheral artery disease, carotid
artery disease, smoking status, hyperlipidemia, systemic
hypertension, diabetes mellitus, and family history of coro-
nary artery disease were as per standard clinical diagnoses,
and had previously been described in detail (5).
Criteria defining the outcomes of interest were specified
a priori. The patients with any of these outcomes on or
before the date of baseline echocardiogram were excluded
from the study. The type and date of detection of each
outcome were abstracted. Congestive heart failure was
defined according to Framingham criteria, requiring the
presence of two major, or one major and two minor
Framingham criteria (6). A history of MI was considered
present if 2 of the three diagnostic criteria were fulfilled:
compatible clinical presentation, diagnostic cardiac enzyme
levels, and electrocardiographic changes consistent with MI.
Coronary revascularization referred to coronary artery by-
pass grafting or percutaneous coronary intervention. Atrial
fibrillation was defined as the presence of clinically docu-
mented and electrocardiographically confirmed irregular
rhythm with disorganized atrial activity and without discrete
P-waves. Stroke in this study included development of any
type of stroke, as defined by clinical documentation of the
diagnosis with confirmatory findings on imaging studies. A
TIA was defined by the clinical documentation of the
diagnosis, in the absence of other conditions that could be
responsible for the neurological symptoms.
Left atrial (LA) volume was measured offline using the
biplane area-length method (7) and was indexed to body
surface area (indexed LA volume). The cardiologists mea-
suring LA volume were blinded to patients’ clinical data and
outcome status. All other echocardiographic data were
retrieved electronically from the computerized echocardio-
graphic database.
The transmitral Doppler flow profile is integral to the
assessment of diastolic function (8). Abnormal relaxation is
the mildest form of diastolic dysfunction. In our study, the
presence of mitral E/A0.75 or deceleration time240 ms
was considered evidence of abnormal relaxation. In patients
with pseudonormal LV filling, or moderate diastolic dys-
function, transmitral flow characteristics are similar to those
observed in normal diastolic function, although the left
atrium is typically enlarged from elevated LV filling pres-
sures. In this study, both pseudonormal and normal LV
filling were defined by the presence of mitral E/A of 0.75 to
1.5 and deceleration time of 151 to 240 ms, but distin-
guished by whether LA volume was 28 ml/m2 (pseudo-
normal) or 28 ml/m2 (normal) (9). The severe form of
diastolic dysfunction is characterized by the presence of
restrictive diastolic filling with markedly elevated filling
pressures (8). In this study, the presence of mitral E/A1.5
or deceleration time 150 ms was considered evidence of
restrictive diastolic filling. Unlike other transmitral flow
parameters, isovolumic relaxation time was not routinely
measured during the study period and was therefore not
used for analyses.
Outcome ascertainment. The outcomes of interest for this
study were first documented MI, coronary revascularization,
CHF, AF, stroke, TIA, and cardiovascular death. The
ascertainment of any of these outcomes was accomplished
through comprehensive review of the medical records and
cross-referencing the multiple administrative databases
available (medical, surgical, electrocardiography, and echo-
cardiography) to detect any inconsistencies. The same
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definitions and criteria for adjudication of events were used
for all patients throughout the study period.
Statistical methods. Differences in baseline characteristics
between patients who did and did not develop outcome
events of interest after baseline echocardiography were
assessed using chi-square analyses for categorical variables
(Table 1). For continuous variables, two-sample t tests were
used for variables that had a normal distribution, and
Wilcoxon rank-sum tests for those with a non-normal
distribution. Descriptive statistics for both groups were
tabulated as means and standard deviations (SD) or fre-
quency percentages.
To evaluate the incremental prognostic value of echocar-
diographic variables, the global log likelihood ratio chi-
square statistics for models developed using: 1) clinical risk
factors alone; 2) echocardiographic variables alone; and 3)
combined clinical and echocardiographic variables were
determined by Cox proportional hazards regression. In all
cases, statistical significance was defined as two-tailed p 
0.05.
Development of model and risk-scoring algorithm.
Using Cox proportional hazards analyses, age- and gender-
adjusted models, as well as models with multiple adjust-
ments, were developed to estimate the associations between
clinical and echocardiographic variables, and time to first
cardiovascular event. From these models, hazard ratios
(HR), 95% confidence intervals (CI), and the associated p
values were generated. Ordinal versions of each of the
echocardiographic variables of the multivariate model, with
two to four levels, were created, and represented by thresh-
old indicator variables. When a certain echocardiographic
measurement was missing in a patient, an additional level
(missing) for that variable was assigned. With the exception
of age, the clinical variables were dichotomous.
Next, a backward stepwise Cox regression procedure was
used, starting with the four clinical variables and 14 echo-
cardiographic indicator variables. In addition to requiring
that each variable remain significant at p 0.05 level, it was
also mandated that the degree of risk change unidirection-
ally with each step-up in level for all echocardiographic
variables. The missing category for each echocardiographic
variable was simply combined with whichever of the corre-
sponding ordinal levels it most closely resembled in relative
risk.
Finally, a risk score was developed by assigning small
integer values to each category (clinical or echocardiograph-
ic), which were approximately proportional to the model-
based log hazard differences between the categories. The log
(hazard) associated with a 10-year age increase was similarly
converted to an integer value. It was anticipated that the
resulting score would account appropriately for the missing
values, and therefore would be generalizable to other situ-
ations with different patterns of missingness. Cumulative
event-free survival, stratified by three risk groups (low-,
medium-, and high-risk scores), was estimated by Kaplan-
Meier analysis.
Validation of model and score. The multivariate model
for prediction and risk scoring algorithm were displayed in
Tables 2 and 3. We investigated the robustness of the model
using two approaches. First, a bootstrap (10) resampling
study (n  500) was done relative to the backward stepwise
procedure to determine the likelihood that all of the clinical
and echocardiographic variables in our final models would
appear also in the final model of these bootstrap samples. It
Table 1. Baseline Clinical, Electrocardiographic, and Echocardiographic Characteristics of Study
Population Stratified by Event Status





Age, mean  SD, yr (1,160) 77  7 74  6  0.001*
Men, % (1,160) 38 35 0.269
Pulse rate, mean  SD, beats/min (1,117) 67  19 64  18 0.044
Systolic blood pressure, mean  SD, mm Hg (948) 146  23 142  23 0.011
Pulse pressure, mean  SD, mm Hg (948) 67  19 64  18 0.044
History of hypertension, % (1,160) 63 48  0.001
History of vascular disease, % (960) 26 13  0.001
History of diabetes mellitus, % (1,160) 11 7 0.026
LVH on ECG, % (1,160) 6 3 0.043
M-mode LA dimension, mean  SD, mm (1,014) 41  7 40  6 0.001*
LA volume, mean  SD, ml (1,018) 64  22 56  21  0.001*
Indexed LA volume, mean  SD, ml/m2 (1,018) 36  12 31  12  0.001
LV diastolic septal wall thickness, mean  SD, mm (765) 12  3 11  2  0.001*
LV diastolic posterior wall thickness, mean  SD, mm (792) 11  2 10  2  0.001*
LV mass/height, mean  SD, g/m (733) 131  44 109  26  0.001*
LV ejection fraction, mean  SD, % (866) 61  11 63  9 0.018*
*Rank-sum test was used. Other variables that did not differ significantly between the two groups: weight, height, body surface
area, body mass index, diastolic blood pressure, hyperlipidemia, smoking (current or past), family history of coronary artery
disease, chronic obstructive pulmonary disease, LV end-systolic and end-diastolic dimensions, pulmonary venous systolic and
diastolic forward flow velocities, pulmonary venous atrial reversal velocity, mitral peak E and peak A velocities, mitral early
deceleration time, and tricuspid regurgitation velocity.
ECG  electrocardiography; LA  left atrial; LV  left ventricular; LVH  left ventricular hypertrophy.
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was not required that the same set of threshold variables for
each echocardiographic variable be selected, but merely that
the variable was represented by at least one of the threshold
variables.
The second method of validation was to apply the model
to a separate population of a prospective study (referred
from here on as the prospective validation cohort). In this
prospective cohort, all 410 patients were referred to the
echocardiography laboratory subsequent to 1998, and were
recruited and followed prospectively. A total of 62 outcome
events occurred during a two-year follow-up in this pro-
spective cohort. This prospective study had no residency
requirement and included many non-Olmsted County res-
idents. The final model (ordinal variable version) was
re-estimated on this prospective validation cohort, and the
model chi-square statistics (normalized to the number of
events) compared. In addition, risk scores were calculated
for the 410 patients in the prospective validation cohort, and
used to stratify the patients in the same way as in study
cohort. The corresponding Kaplan-Meier event-free sur-
vival curves were generated and compared with those of the
study cohort. The empiric risk estimates at year 1 and year
2 were compared between the study population and the
prospective validation cohort (Table 4).
RESULTS
Baseline characteristics of the study population. A total
of 1,160 residents (746 women; 414 men) of Olmsted
County, Minnesota, mean age 75  7 years (range 65 to
100 years) fulfilled all study criteria and constituted the
study population. The principal indications for echocardio-
graphic assessment were dyspnea (32%), chest discomfort
(20%), palpitations, lightheadedness, presyncope or syncope
(18%), cardiac function assessment (20%), murmurs (8%),
and other reasons (2%). Further review of the records of the
group of patients with a referral indication of “cardiac
function assessment” showed that 38% had dyspnea as a
predominant symptom, 32% had chest discomfort, 20% had
fatigue, and 10% had various combinations of these symp-
toms. Over a mean follow-up period of 3.8 2.7 years, 333
(29%) patients had a total of 536 events of interest. A total
of 307 patients died during the follow-up period. First
events (n  333) included 70 AF, 67 coronary revascular-
ization procedures, 65 CHF, 48 MI, 38 stroke, 25 TIA, and
20 cardiovascular deaths. A number of baseline character-
istics differed between the patients who had 1 outcome
event versus those who did not have an event during
follow-up (Table 1). The majority of the patients (1,113
patients; 96%) had normal LV systolic function with ejec-
tion fraction 50%. Left ventricular diastolic function was
classified as normal in 150 patients, mildly abnormal (ab-
Table 2. Multivariate Model for Prediction of First Age-Related Events
Variables
Parameter
Estimate HR (95% CI) p
Age, yrs 0.06 1.06 (1.04–1.08)  0.001
Male gender 0.41 1.50 (1.19–1.88)  0.001
Diabetes mellitus 0.50 1.64 (1.16–2.32) 0.005
Systemic hypertension 0.50 1.64 (1.30–2.06)  0.001
Indexed LA volume  32 ml/m2 0.35 1.42 (1.13–1.78) 0.003
LV mass/height  120 g/m 0.45 1.57 (1.10–2.26) 0.014
LV ejection fraction  50% 0.80 2.22 (1.44–3.42)  0.001
Presence of any diastolic dysfunction 0.49 1.64 (1.10–2.55) 0.029
*p  0.05 for the following variables: systolic blood pressure, diastolic blood pressure, pulse pressure, pulse rate, hyperlipidemia,
carotid artery disease, smoking (current or past), chronic obstructive pulmonary disease.
CI  confidence interval; HR  hazard ratio; LA  left atrial; LV  left ventricular.






Age 65–69.9 yrs 0
Age 70–74.9 yrs 1
Age 75–79.9 yrs 2
Age 80–84.9 yrs 3





LV ejection fraction  50% or missing 0
LV ejection fraction  50% 2
Normal diastolic function 0
Any diastolic dysfunction or missing 1
Indexed LA volume  32 ml/m2 or missing 0
Indexed LA volume  32 ml/m2 1
LV mass/height 120 g/m or missing 0
LV mass/height 120 g/m 1
LA  left atrial; LV  left ventricular.
Table 4. Kaplan-Meier Event Rates for the Study Population
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normal relaxation) in 473 patients, moderately abnormal
(pseudonormal) in 192 patients, and severely abnormal
(restrictive) in 32 patients.
Prediction of first age-related cardiovascular events. AGE
AND GENDER-ADJUSTED MODELS FOR PREDICTION OF
FIRST EVENTS. When adjusted for both age and gender, the
significant clinical and echocardiographic predictors in-
cluded age (per year) (HR 1.06; 95% CI 1.05 to 1.08; p 
0.001); male gender (HR 1.20; 95% CI 0.96 to 1.50; p 
0.105); body mass index (per 5 kg/m2) (HR 1.02; 95% CI
1.01 to 1.05; p  0.037); systemic hypertension (HR 1.75;
95% CI 1.40 to 2.19; p  0.001); coronary artery disease
(HR 1.85; 95% CI, 1.08 to 3.17; p  0.025); diabetes
mellitus (HR 1.84; 95% CI 1.31 to 2.60; p  0.001), and
the following echocardiographic variables: indexed LA vol-
ume (per 10 ml/m2) (HR 1.29; 95% CI 1.19 to 1.40; p 
0.001); LV end-systolic dimension (per 5 mm) (HR 1.23;
95% CI 1.10 to 1.36; p  0.001); LV ejection fraction (per
10%) (HR 0.77; 95% CI 0.68 to 0.86; p  0.001); LV
mass/height (per 10 g/m) (HR 1.01; 95% CI 1.01 to 1.02;
p 0.001); and presence of diastolic dysfunction (HR 1.36;
95% CI 1.16 to 1.60; p  0.001).
MULTIVARIATE MODEL FOR PREDICTION OF FIRST
EVENTS. A multivariate model was developed for the pre-
diction of first events. This contained four clinical and four
echocardiographic variables, all statistically independent of
each other: age, gender, diabetes mellitus, systemic hyper-
tension, LV systolic function, LV diastolic function, LV
mass, and LA volume (Table 2). The global log likelihood
ratio chi-square statistics for the models containing: 1) the
four clinical risk factors only; 2) the four echocardiographic
variables only; and 3) combined four clinical and four
echocardiographic variables were 99, 54, and 143 (vs. 99 or
54, p  0.001), respectively. We also tested for any
independent predictive value of symptoms (chest pain,
dyspnea, lightheadedness, palpitations, presyncope, synco-
pe), and found that presenting symptoms that led to
echocardiography referral were not independently predictive
of first events in univariate or multivariate model. Also,
adding symptoms to the multivariate model with the eight
independent clinical and echocardiographic variables (Table
2) did not diminish the predictive value of any of the
parameters in the model.
RISK-SCORING ALGORITHM FOR PREDICTION OF FIRST
EVENTS. A risk score was generated for each patient based
on the multivariate model of four clinical and four echocar-
diographic variables, using the method outlined in the
Methods section. The minimum score was 0 and the
maximum score was 12 (Table 3). The Kaplan-Meier
five-year event-free survival stratified by low (2), medium
(3 to 4), and high (5) risk scores were 90%, 74%, and 50%
(Fig. 1).
The risk score was validated both within the study
population, as well as in a prospective validation cohort of
410 patients (see Methods). Within the study population
from which 500 random samples were drawn by the
bootstrapping technique, only 2% did not include at least
seven of the eight predictor variables of the multivariate
model. This means that the multivariate model was highly
stable when subjected to random sampling within the study
population. Notably, indexed LA volume was the only
echocardiographic variable that appeared in 100% of the
samples in this random sampling. The risk score in this
study population was associated with a HR of 1.44 (95% CI
1.35 to 1.53; p  0.001), so that every increment of one
point was associated with a hazard increase of 44%.
We also validated the model and risk score with a
completely separate population of 410 patients, who were
referred to the echocardiography laboratory and followed
prospectively in a different study. Over a two-year follow-
up, a total of 62 outcome events developed. In this prospec-
tive population, the model fitting was highly acceptable
(global model chi-square of 38 for 62 events, versus global
model chi-square of 143 for 333 events in the study
population). The risk score calculated for the prospective
validation cohort was associated with a HR of 1.40 (95% CI
1.25 to 1.58; p  0.001). Thus, the hazard associated with
the risk score in the study population (HR 1.44) and that
with the validation cohort (HR 1.40) compared closely.
Further, the Kaplan-Meier event-free survival curves for the
prospective validation cohort and the study population
compared closely, when stratified by the low-, medium-,
and high-risk scores, as did the estimated cumulative event
rates at one and two years (Fig. 2, Table 4).
DISCUSSION
Prediction of age-related cardiovascular events in the
elderly: beyond clinical risk factor assessment. This study
provides evidence that assessment of certain subclinical
parameters by noninvasive echocardiography improves risk
stratification for the development of first age-related car-
diovascular events in the elderly. The events considered in
Figure 1. Kaplan-Meier estimates of cumulative event-free survival for the
study population.
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this study are common age-related conditions. Nearly one-
third of the entire cohort who were free from any events of
interest at baseline developed at least one event during a
mean follow-up time of only 3.8 years.
Advancing age, male gender, systemic hypertension, and
diabetes mellitus are well-established cardiovascular risk
factors, and were independent predictors of first events in
this study, even after echocardiographic parameters were
added to the model. From the risk modification standpoint,
chronologic age and male gender are immutable. In con-
trast, systemic hypertension is highly treatable, yet has
remained grossly undertreated in the community (11,12).
Diabetes mellitus is a potent cardiovascular risk factor, and
is now considered equivalent to established coronary heart
disease in terms of its status as a risk factor (13). Early
diagnosis and control of this metabolic disease has major
implications on cardiovascular outcomes. Although there
are abundant data on the impact of detection and treatment
of these clinical risk factors on cardiovascular outcomes,
there is a paucity of data with regard to assessment and
treatment of echocardiographic risk markers.
The echocardiographic predictors of first events identified
in this study can be readily obtained with any echocardiog-
raphy system, including the more advanced hand-held
devices. Based on the multivariate model in this study
(Table 2), simple identification of whether an elderly
individual has: 1) abnormal systolic function (LV ejection
fraction 50%); 2) evidence of any diastolic dysfunction; 3)
LA volume/body surface area 32 ml/m2 (2 SD from the
normal mean value); and 4) LV mass/height of 120 g/m
contributes to the prediction of first events. Although LV
systolic function (14,15), diastolic function (5,16), and mass
(17) have been shown to be important prognostic indicators
for various cardiovascular outcomes, few studies have dem-
onstrated LA volume to be independent of all these echo-
cardiographic risk markers, and of clinical risk factors, for
the prediction of the first cardiovascular events in the
elderly. Notably, LA volume was the only echocardio-
graphic predictor that was represented in the model for each
of the 500 samples randomly drawn from the study popu-
lation in the risk score validation procedure, attesting to its
robustness as a predictor for first events.
Symptoms that led to echocardiographic referral, such as
chest pain, dyspnea, palpitations, lightheadedness, presyn-
cope, or syncope, were not independently predictive of first
events. This could be related to the relatively nonspecific
nature of these symptoms, which are often subjective and
not readily quantifiable. In contrast, echocardiography pro-
vides a more objective, quantifiable, and reproducible as-
sessment.
Risk-scoring algorithm for prediction of first events in
the elderly. A risk-scoring algorithm was developed in this
study, based on the multivariate model for the prediction of
first events, which was validated both within the study
population and in a separate cohort containing 410 patients
followed prospectively for two years. The Framingham
investigators have been instrumental in the development of
algorithms for risk stratification and event prediction. The
Framingham data used to generate equations for estimating
risk of manifest cardiovascular disease were derived from a
middle-aged population of white men and women (18), and
not from an elderly population as in this study. The
Framingham investigators had also described a general
stroke risk profile (19,20), as had the investigators of Israeli
Ischemic Heart Disease project (21) and the Cardiovascular
Health Study (22). Subclinical risk factors, such as those
measured by echocardiography in our study, have not been
included in these risk-scoring algorithms. Further, most
risk-scoring methods to date were developed to predict a
specific condition. Therefore, different risk prediction rules
have to be applied to estimate the risks for different
outcomes of interest. The clinical application of multiple
metrics for quantifying the risks for different events can be
intimidating. In the case of primary prevention of a first
cardiovascular event, it is desirable to having a simple
unifying algorithm that enables point-of-care risk stratifi-
cation for common age-related conditions that share similar
risk factors, such as AF, stroke, MI, CHF, revascularization,
and cardiovascular death.
The feasibility of utilizing echocardiography to screen the
elderly population for subclinical predictors and applying a
simple scoring algorithm for risk stratification requires
prospective investigation. The impact of detection and
treatment of these abnormalities on cardiovascular outcomes
and the cost-effectiveness of such a program will need to be
determined. With the availability of highly sophisticated
hand-held echocardiographic devices that now allow mea-
surement of these subclinical parameters readily in an office
setting, the future possibility of applying noninvasive echo-
cardiographic technology effectively at the point of care for
Figure 2. Comparison of Kaplan-Meier estimates of cumulative event-free
survival between the study population and the prospective validation
cohort, stratified by risk groups.
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risk stratification in primary prevention is appealing and
warrants further investigation.
Study limitations. This is a retrospective referral-based
cohort study, and subject to biases inherent to the design.
The majority of this elderly cohort was of Caucasian descent,
and the generalizability of the findings to other racial/ethnic
groups and to non-referral-based populations could not be
determined. Outcome ascertainment, based on chart review,
might have underestimated the number of events. However,
given the relative geographic isolation of Olmsted County, and
the near exclusive utilization of Mayo Clinic as the health
provider by the residents of this county (4), it is relatively
unlikely that the underestimation would be significant.
Because of the era in which the echocardiograms were
performed, pulmonary venous flow velocities and tissue
Doppler mitral annular velocities were not available in a
significant number of the patients. The categorization of
diastolic function status was based on simple mitral inflow
characteristics and LA volume, and therefore, misclassifica-
tion of diastolic function status was possible.
The echocardiographic variables in the multivariate
model for the prediction of first events were purposely defined
categorically to preserve simplicity. It is possible that the ability
to predict first age-related cardiovascular events may be further
enhanced if the echocardiographic variables were evaluated as
continuous variables. Such a model, however, would be more
cumbersome to use clinically.
In this study, we also did not develop a unique prediction
model specific for each outcome event. Our intent was to
develop a unifying prediction metric, or risk-scoring
method, for estimating the overall risk for first cardiovas-
cular events of interest that share similar risk factors. This
risk stratification approach does sacrifice event-specific pre-
diction, but is eminently more practical and feasible. Al-
though the risk-scoring algorithm was validated within the
study population, and also in a separate referral-based
population prospectively followed for outcome events, fur-
ther validation procedures using community-based non-
referral-based populations would be important.
Conclusions. The noninvasive echocardiographic identifi-
cation of subclinical risk markers, such as LV systolic or
diastolic dysfunction, enlarged left atrium, and increased LV
mass, enhanced risk stratification for the development of
first age-related cardiovascular events in our referral-based
elderly cohort, incremental to clinical risk profiling alone.
Prospective studies to confirm these findings in other
populations, including community free-living individuals,
and to determine the cost-effectiveness of primary preven-
tion programs that incorporate echocardiographic evalua-
tion in risk stratification for first events in the elderly may
have important public health implications.
Reprint requests and correspondence: Dr. Teresa S. M. Tsang,
Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.
E-mail: tsang.teresa@mayo.edu.
REFERENCES
1. Scheinman MM. Atrial fibrillation and congestive heart failure: the
intersection of two common diseases. Circulation 1998;98:941–2.
2. Braunwald E. Shattuck lecture: cardiovascular medicine at the turn of
the millennium: triumphs, concerns and opportunities. N Engl J Med
1997;337:1360–9.
3. 2003 Heart and Stroke Statistical Update. Dallas, TX: American
Heart Association, 2002.
4. Melton LJ. History of the Rochester Epidemiology Project. Mayo
Clin Proc 1996;71:266–74.
5. Tsang TSM, Gersh BJ, Tajik AJ, et al. Left ventricular diastolic
dysfunction: an important predictor of the first diagnosed nonvalvular
atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol
2002;40:1636–44.
6. McKee P, Castelli W, McNamara P, Kannel W. The natural history
of congestive heart failure: the Framingham Study. N Engl J Med
1971;285:1441–6.
7. Ren J-F, Kotler MN, DePace NL, et al. Two-dimensional echocar-
diographic determination of left atrial emptying volume: a noninvasive
index in quantifying the degree of nonrheumatic mitral regurgitation.
J Am Coll Cardiol 1983;2:729–36.
8. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle
in health and disease: Doppler echocardiography is the clinician’s
Rosetta Stone. J Am Coll Cardiol 1997;30:8–18.
9. Tsang T, Barnes M, Gersh B, Bailey K, Seward J. Left atrial volume
as a morphophysiologic expression of diastolic dysfunction and relation
to cardiovascular risk burden. Am J Cardiol 2002;90:1284–9.
10. Efron B. The jackknife, the bootstrap and other resampling plans.
Regional Conference Series in Applied Mathematics, 38. SIAM,
Philadelphia, PA: 1982.
11. Meissner I, Whisnant JP, Sheps SG, et al. Detection and control of
high blood pressure in the community: do we need a wake-up call?
Hypertension 1999;34:466–71.
12. He J, Muntner P, Chen J, Roccella E, Streiffer R, Whelton P. Factors
associated with hypertension control in the general population of the
United States. Arch Intern Med 2002;162:1051–8.
13. Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults. Executive Summary of the Third
Report of the National Cholesterol Education Program (NCEP)
Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:
2486–97.
14. The SOLVED Investigators. Effect of enalapril on survival in patients
with reduced left ventricular ejection fraction and congestive heart
failure. N Engl J Med 1991;325:293–302.
15. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on
mortality and morbidity in patients with left ventricular dysfunction
after myocardial infarction. Results of the survival and ventricular
enlargement trial. The SAVE Investigators. N Engl J Med 1992;327:
669–77.
16. Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR,
Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction
in the community. JAMA 2003;289:194–202.
17. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prog-
nostic implications of echocardiographically determined left ventricu-
lar mass in the Framingham Heart Study. N Engl J Med 1990;322:
1561–6.
18. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H,
Kannel WB. Prediction of coronary heart disease using risk factor
categories. Circulation 1998;97:1837–47.
19. Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of
stroke: a risk profile from the Framingham Study. Stroke 1991;22:
312–8.
20. D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk
profile: adjustment for antihypertensive medication. The Framingham
Study. Stroke 1994;25:40–3.
21. Tanne D, Yaari S, Goldbourt U. Risk profile and prediction of
long-term ischemic stroke mortality. Circulation 1998;98:1365–71.
22. Lumley T, Kronmal R, Cushman M, Manolio T, Goldstein S. A
stroke prediction score in the elderly: validation and web-based
application. J Clin Epidemiol 2002;55:129–36.
1205JACC Vol. 42, No. 7, 2003 Tsang et al.
October 1, 2003:1199–205 Age-Related Cardiovascular Events
